Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurien J Zeverijn

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer Discovery|June 1, 2022
Can Drug Repurposing Accelerate Precision Oncology?Luuk J Schipper, Laurien J Zeverijn, Mathew J Garnett, et al.
The Lancet. Oncology|April 30, 2022
The DRUG Access Protocol: access inequality and European harmonisation - Authors' replySahar Barjesteh van Waalwijk van Doorn-Khosrovani, Laurien J Zeverijn, Emile E Voest
Hypertension in Pregnancy|September 28, 2020
Maternal recall of a history of early-onset preeclampsia, late-onset preeclampsia, or gestational hypertension: a validation studyAnouk Bokslag, Anne B Fons, Laurien J Zeverijn, et al.
The Oncologist|April 22, 2023
Beyond Skin Rash: Alpelisib-Induced Anaphylactic ReactionsTim Schutte, Laurien J Zeverijn, Birgit S Geurts, et al.
Cell Reports. Medicine|January 27, 2026
Liver metastases dampen IL18-driven γδ T cell activity and immunotherapy responsiveness in colorectal cancerAllard W J van Renterghem, Miguel Parra-Martinez, Maartje Witsen, et al.
Acta Oncologica (Stockholm, Sweden)|May 23, 2024
The evolution of precision oncology: The ongoing impact of the Drug Rediscovery Protocol (DRUP)Soemeya F Haj Mohammad, Hans J L Timmer, Laurien J Zeverijn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2024
Maximizing Treatment Opportunities: Assessing Protocol Waivers' Impact on Safety and Outcome in the Drug Rediscovery ProtocolJade M van Berge Henegouwen, Laurien J Zeverijn, Birgit S Geurts, et al.
Cell|April 10, 2024
A pan-cancer analysis of the microbiome in metastatic cancerThomas W Battaglia, Iris L Mimpen, Joleen J H Traets, et al.
International Journal of Cancer|October 16, 2025
Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocolIlse A C Spiekman, Niven Mehra, Laurien J Zeverijn, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2026
BRAF<sup>V600E</sup>-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery ProtocolSoemeya F Haj Mohammad, Ilse A C Spiekman, Karlijn Verkerk, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer Discovery|June 1, 2022
Can Drug Repurposing Accelerate Precision Oncology?Luuk J Schipper, Laurien J Zeverijn, Mathew J Garnett, et al.
The Lancet. Oncology|April 30, 2022
The DRUG Access Protocol: access inequality and European harmonisation - Authors' replySahar Barjesteh van Waalwijk van Doorn-Khosrovani, Laurien J Zeverijn, Emile E Voest
Hypertension in Pregnancy|September 28, 2020
Maternal recall of a history of early-onset preeclampsia, late-onset preeclampsia, or gestational hypertension: a validation studyAnouk Bokslag, Anne B Fons, Laurien J Zeverijn, et al.
The Oncologist|April 22, 2023
Beyond Skin Rash: Alpelisib-Induced Anaphylactic ReactionsTim Schutte, Laurien J Zeverijn, Birgit S Geurts, et al.
Cell Reports. Medicine|January 27, 2026
Liver metastases dampen IL18-driven γδ T cell activity and immunotherapy responsiveness in colorectal cancerAllard W J van Renterghem, Miguel Parra-Martinez, Maartje Witsen, et al.
Acta Oncologica (Stockholm, Sweden)|May 23, 2024
The evolution of precision oncology: The ongoing impact of the Drug Rediscovery Protocol (DRUP)Soemeya F Haj Mohammad, Hans J L Timmer, Laurien J Zeverijn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2024
Maximizing Treatment Opportunities: Assessing Protocol Waivers' Impact on Safety and Outcome in the Drug Rediscovery ProtocolJade M van Berge Henegouwen, Laurien J Zeverijn, Birgit S Geurts, et al.
Cell|April 10, 2024
A pan-cancer analysis of the microbiome in metastatic cancerThomas W Battaglia, Iris L Mimpen, Joleen J H Traets, et al.
International Journal of Cancer|October 16, 2025
Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocolIlse A C Spiekman, Niven Mehra, Laurien J Zeverijn, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2026
BRAF<sup>V600E</sup>-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery ProtocolSoemeya F Haj Mohammad, Ilse A C Spiekman, Karlijn Verkerk, et al.
Pageof 3